Illumina, Inc (ILMN) DRAGEN v4.5 supports Illumina’s new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

Newsdesk: